Live feed
Filing
SC 13G/A
SC 13G/A0001493152-18-001805·GENESIS CAPITAL ADVISORS LLC
Schedule 13G ownership disclosure
ZYNERBA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98986X109
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 749,640
- Percent of class
- 5.5300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-18-001805
- Form type
- SC 13G/A
- Filer
- GENESIS CAPITAL ADVISORS LLC
- CIK
- CIK 1439253
- Filed
- Feb 12, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership